일회용 바이오리액터 시장 - 세계 산업 규모, 점유율, 동향, 기회, 예측 : 제품 유형별, 세포 유형별, 분자 유형별, 용도별, 최종 용도별, 지역별, 경쟁별(2020-2030년)
Single-Use Bioreactors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Type, By Type of Cell, By Molecule, By Application, By Usage, By End User, By Region & Competition, 2020-2030F
상품코드:1770815
리서치사:TechSci Research
발행일:2025년 07월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
일회용 바이오리액터(서브 테마) 세계 시장은 2024년에 23억 달러로 평가되었으며, 예측 기간 동안 CAGR 12.85%로 성장하여 2030년에는 47억 5,000만 달러에 달할 것으로 예측됩니다.
시장 성장을 주도하는 것은 연구개발 활동의 활성화, 공동 연구의 확대, 새로운 백신 및 치료제에 대한 수요 증가입니다. 만성질환 및 감염성 질환의 증가와 함께 단클론항체의 시장 개척은 시장 확대를 더욱 촉진하고 있으며, SUB는 기존의 스테인리스 스틸 시스템을 대체할 수 있는 확장성과 비용 효율성이 뛰어나 임상 및 상업용 생산에 매력적인 대안이 될 수 있습니다. 매력적인 제품입니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
23억 달러
시장 규모 : 2030년
47억 5,000만 달러
CAGR : 2025-2030년
12.85%
급성장 부문
유전자 재조합 세포
최대 시장
북미
예를 들어, 2022년 1월, HaemaLogiX Ltd는 Lonza와 제휴하여 κ 골수종 항원을 표적으로 하는 단클론항체 KappaMab의 임상 배치를 생산했습니다. 또한, 생물학적 제제의 급속한 보급, 생물학적 제제 연구에 대한 정부의 자금 지원, 맞춤형 의료에 대한 관심 증가는 전 세계 제약 및 바이오의약품 부문 전반에 걸쳐 SUB에 대한 수요를 촉진하고 있습니다. 오염 위험 감소, 처리 시간 단축, 최소한의 세척 요구 사항 등의 장점으로 인해 SUB는 최신 바이오 공정 작업에서 점점 더 필수적인 요소가 되고 있습니다.
시장 촉진요인
바이오의약품 수요와 바이오시밀러 생산 급증
주요 시장 동향
바이오프로세스에 디지털 기술 통합
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 일회용 바이오리액터 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
제품별(일회용 바이오리액터 시스템, 일회용 미디어 백, 일회용 여과 어셈블리, 기타 제품)
유형별(교반조형 SUB, 파동 야기형 SUB, 기포탑형 SUB, 기타 SUB)
세포 종류별(포유류 세포, 세균 세포, 효모 세포, 기타 세포)
분자별(단클론항체, 백신, 유전자 재조합 세포, 줄기세포, 기타 분자)
용도별(연구개발, 바이오 프로덕션)
용도별(실험실 스케일 생산, 파일럿 스케일 생산, 대규모 생산)
최종사용자별(제약회사, 바이오의약품 회사, CROS 및 CMOS, 학술조사기관)
지역별(북미, 유럽, 아시아태평양, 남미, 중동 및 아프리카)
기업별(2024)
시장 맵
제품별
유형별
세포 종류별
분자별
용도별
용도별
최종사용자별
지역별
제6장 북미의 일회용 바이오리액터 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 일회용 바이오리액터 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
프랑스
독일
영국
이탈리아
스페인
제8장 아시아태평양의 일회용 바이오리액터 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 남미의 일회용 바이오리액터 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 일회용 바이오리액터 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
남아프리카공화국
사우디아라비아
아랍에미리트
제11장 시장 역학
성장 촉진요인
실험실 자동화 활동 수요 증가
바이오뱅크에 의한 검사 정보학의 도입 확대
기술적으로 진보한 소프트웨어 서비스의 도입 증가
과제
연구실 정보과학의 통합 표준의 결여
엄격한 규제
제12장 시장 동향과 발전
최근 동향
인수합병
제품 출시
제13장 세계의 일회용 바이오리액터 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
ABEC, INC.
Able Corporation & Biott Corporation.
BBI-Biotech Gmbh.
Cellexus Biosystems PLC.
Celltainer Biotech BV.
Danaher Corporation
Distek Inc.
Eppendorf AG.
G&G Technologies, Inc.
Getinge AB
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
ksm
영문 목차
영문목차
The Global Single-Use Bioreactors (SUBs) Market was valued at USD 2.30 billion in 2024 and is projected to reach USD 4.75 billion by 2030, growing at a CAGR of 12.85% during the forecast period. The market's growth is driven by increasing research and development activities, expanding collaborations, and heightened demand for novel vaccines and therapeutics. The rise in chronic and infectious diseases, along with the growing development of monoclonal antibodies, further supports market expansion. SUBs offer a scalable and cost-efficient alternative to traditional stainless-steel systems, making them attractive for both clinical and commercial manufacturing.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 2.30 Billion
Market Size 2030
USD 4.75 Billion
CAGR 2025-2030
12.85%
Fastest Growing Segment
Gene Modified Cells
Largest Market
North America
For instance, in January 2022, HaemaLogiX Ltd partnered with Lonza to manufacture a clinical batch of KappaMab, a monoclonal antibody targeting kappa myeloma antigen-demonstrating the role of SUBs in advanced drug development. Additionally, the rapid adoption of biologics, government funding for biologics research, and increased focus on personalized medicine are fostering demand for SUBs across global pharmaceutical and biopharmaceutical sectors. Their benefits, including reduced contamination risk, shorter turnaround times, and minimal cleaning requirements, make them increasingly indispensable in modern bioprocessing operations.
Key Market Drivers
Surge in Biopharmaceutical Demand and Biosimilar Production
The growing demand for biopharmaceutical products-particularly monoclonal antibodies, vaccines, and biosimilars-is a major driver of the single-use bioreactors market. These biologics are increasingly used to treat chronic diseases such as cancer, diabetes, and autoimmune disorders due to their targeted therapeutic effects and lower side effect profiles. SUBs offer a flexible and efficient production solution, reducing the need for time-consuming cleaning and sterilization compared to stainless-steel systems.
Supportive regulatory environments and rising public investment in biologics research are accelerating this shift. For instance, as of March 2024, the U.S. National Institutes of Health allocated USD 47.6 billion in funding, emphasizing biologics and biosimilar development. Similarly, the European Medicines Agency approved a notable number of monoclonal antibodies in 2023. These advancements, alongside favorable government policies, are promoting the adoption of SUBs to meet the evolving demands of large-scale and cost-effective biomanufacturing.
Key Market Trends
Integration of Digital Technologies in Bioprocessing
The integration of digital tools such as IoT, AI, and machine learning into SUB platforms is revolutionizing biomanufacturing practices. These technologies enable real-time monitoring, predictive analytics, and advanced process control-enhancing efficiency, product quality, and compliance.
Referred to as Bioprocessing 4.0, this evolution is being actively supported by regulatory agencies. For example, the U.S. FDA is encouraging the adoption of advanced manufacturing technologies to boost production resilience and safety. As a result, biopharmaceutical firms are increasingly investing in digitalized SUB systems, enabling smarter, faster, and more agile production processes. This synergy between single-use bioreactor platforms and digital transformation is expected to drive sustained improvements in scalability, traceability, and operational performance in the bioprocessing sector.
Key Market Players
ABEC, INC.
Able Corporation & Biott Corporation
BBI-Biotech GmbH
Cellexus Biosystems PLC
Celltainer Biotech BV
Danaher Corporation
Distek Inc.
Eppendorf AG
G&G Technologies, Inc.
Getinge AB
Report Scope:
In this report, the Global Single-Use Bioreactors Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Single-Use Bioreactors Market, By Product:
Single use bioreactor systems
Single use media bags
Single use filtration assemblies
Other products
Single-Use Bioreactors Market, By Type:
Stirred tank SUB
Wave induced SUB
Bubble Column SUB
Other SUB
Single-Use Bioreactors Market, By Type of Cell:
Mammalian Cell
Bacterial Cell
Yeast Cell
Other Cells
Single-Use Bioreactors Market, By Molecule:
Monoclonal Antibodies
Vaccines
Gene Modified Cells
Stem Cells
Other molecules
Single-Use Bioreactors Market, By Application:
Research and Development
Bioproduction
Single-Use Bioreactors Market, By Usage:
Lab scale production
Pilot scale production
Large scale production
Single-Use Bioreactors Market, By End User:
Pharmaceutical and Biopharmaceutical companies
CROSs & CMOS
Academic and Research Institutes
Single-Use Bioreactors Market, By Region:
North America
United States
Mexico
Canada
Europe
France
Germany
United Kingdom
Italy
Spain
Asia-Pacific
China
India
South Korea
Japan
Australia
South America
Brazil
Argentina
Colombia
Middle East and Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Single-Use Bioreactors Market.
Available Customizations:
Global Single-Use Bioreactors Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Single-Use Bioreactors Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
5.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
5.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
5.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
5.2.5. By Application (Research and Development, Bioproduction)
5.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
5.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
5.2.8. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.9. By Company (2024)
5.3. Market Map
5.3.1 By Product
5.3.2 By Type
5.3.3 By Type of Cell
5.3.4 By Molecule
5.3.5 By Application
5.3.6 By Usage
5.3.7 By End User
5.3.5 By Region
6. North America Single-Use Bioreactors Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
6.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
6.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
6.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
6.2.5. By Application (Research and Development, Bioproduction)
6.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
6.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
6.2.8. By Country
6.3. North America: Country Analysis
6.3.1. United States Single-Use Bioreactors Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Type
6.3.1.2.3. By Type of Cell
6.3.1.2.4. By Molecule
6.3.1.2.5. By Application
6.3.1.2.6. By Usage
6.3.1.2.7. By End User
6.3.2. Canada Single-Use Bioreactors Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Type
6.3.2.2.3. By Type of Cell
6.3.2.2.4. By Molecule
6.3.2.2.5. By Application
6.3.2.2.6. By Usage
6.3.2.2.7. By End User
6.3.3. Mexico Single-Use Bioreactors Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Type
6.3.3.2.3. By Type of Cell
6.3.3.2.4. By Molecule
6.3.3.2.5. By Application
6.3.3.2.6. By Usage
6.3.3.2.7. By End User
7. Europe Single-Use Bioreactors Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
7.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
7.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
7.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
7.2.5. By Application (Research and Development, Bioproduction)
7.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
7.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
7.2.8. By Country
7.3. Europe: Country Analysis
7.3.1. France Single-Use Bioreactors Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Type
7.3.1.2.3. By Type of Cell
7.3.1.2.4. By Molecule
7.3.1.2.5. By Application
7.3.1.2.6. By Usage
7.3.1.2.7. By End User
7.3.2. Germany Single-Use Bioreactors Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Type
7.3.2.2.3. By Type of Cell
7.3.2.2.4. By Molecule
7.3.2.2.5. By Application
7.3.2.2.6. By Usage
7.3.2.2.7. By End User
7.3.3. United Kingdom Single-Use Bioreactors Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Type
7.3.3.2.3. By Type of Cell
7.3.3.2.4. By Molecule
7.3.3.2.5. By Application
7.3.3.2.6. By Usage
7.3.3.2.7. By End User
7.3.4. Italy Single-Use Bioreactors Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Type
7.3.4.2.3. By Type of Cell
7.3.4.2.4. By Molecule
7.3.4.2.5. By Application
7.3.4.2.6. By Usage
7.3.4.2.7. By End User
7.3.5. Spain Single-Use Bioreactors Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Type
7.3.5.2.3. By Type of Cell
7.3.5.2.4. By Molecule
7.3.5.2.5. By Application
7.3.5.2.6. By Usage
7.3.5.2.7. By End User
8. Asia-Pacific Single-Use Bioreactors Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
8.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
8.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
8.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
8.2.5. By Application (Research and Development, Bioproduction)
8.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
8.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
8.2.8. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Single-Use Bioreactors Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Type
8.3.1.2.3. By Type of Cell
8.3.1.2.4. By Molecule
8.3.1.2.5. By Application
8.3.1.2.6. By Usage
8.3.1.2.7. By End User
8.3.2. India Single-Use Bioreactors Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Type
8.3.2.2.3. By Type of Cell
8.3.2.2.4. By Molecule
8.3.2.2.5. By Application
8.3.2.2.6. By Usage
8.3.2.2.7. By End User
8.3.3. Japan Single-Use Bioreactors Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Type
8.3.3.2.3. By Type of Cell
8.3.3.2.4. By Molecule
8.3.3.2.5. By Application
8.3.3.2.6. By Usage
8.3.3.2.7. By End User
8.3.4. South Korea Single-Use Bioreactors Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Type
8.3.4.2.3. By Type of Cell
8.3.4.2.4. By Molecule
8.3.4.2.5. By Application
8.3.4.2.6. By Usage
8.3.4.2.7. By End User
8.3.5. Australia Single-Use Bioreactors Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Type
8.3.5.2.3. By Type of Cell
8.3.5.2.4. By Molecule
8.3.5.2.5. By Application
8.3.5.2.6. By Usage
8.3.5.2.7. By End User
9. South America Single-Use Bioreactors Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
9.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
9.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
9.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
9.2.5. By Application (Research and Development, Bioproduction)
9.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
9.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
9.2.8. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Single-Use Bioreactors Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Type
9.3.1.2.3. By Type of Cell
9.3.1.2.4. By Molecule
9.3.1.2.5. By Application
9.3.1.2.6. By Usage
9.3.1.2.7. By End User
9.3.2. Argentina Single-Use Bioreactors Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Type
9.3.2.2.3. By Type of Cell
9.3.2.2.4. By Molecule
9.3.2.2.5. By Application
9.3.2.2.6. By Usage
9.3.2.2.7. By End User
9.3.3. Colombia Single-Use Bioreactors Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Type
9.3.3.2.3. By Type of Cell
9.3.3.2.4. By Molecule
9.3.3.2.5. By Application
9.3.3.2.6. By Usage
9.3.3.2.7. By End User
10. Middle East and Africa Single-Use Bioreactors Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Single use bioreactor systems, Single use media bags, Single use filtration assemblies, other products)
10.2.2. By Type (Stirred tank SUB, Wave induced SUB, Bubble Column SUB, Other SUB)
10.2.3. By Type of Cell (Mammalian Cell, Bacterial Cell, Yeast Cell, Other Cells)
10.2.4. By Molecule (Monoclonal Antibodies, Vaccines, Gene Modified Cells, Stem Cells, Other molecules)
10.2.5. By Application (Research and Development, Bioproduction)
10.2.6. By Usage (Lab scale production, Pilot scale production, large scale production)
10.2.7. By End User (Pharmaceutical and Biopharmaceutical companies, CROSs & CMOS, Academic and Research Institutes)
10.2.8. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Single-Use Bioreactors Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Type
10.3.1.2.3. By Type of Cell
10.3.1.2.4. By Molecule
10.3.1.2.5. By Application
10.3.1.2.6. By Usage
10.3.1.2.7. By End User
10.3.2. Saudi Arabia Single-Use Bioreactors Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Type
10.3.2.2.3. By Type of Cell
10.3.2.2.4. By Molecule
10.3.2.2.5. By Application
10.3.2.2.6. By Usage
10.3.2.2.7. By End User
10.3.3. UAE Single-Use Bioreactors Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Type
10.3.3.2.3. By Type of Cell
10.3.3.2.4. By Molecule
10.3.3.2.5. By Application
10.3.3.2.6. By Usage
10.3.3.2.7. By End User
11. Market Dynamics
11.1. Drivers
11.1.1 Growing demand for lab automation activities
11.1.2 Growing adoption of lab informatics by biobanks
11.1.3 Growing introduction of technologically advanced software services
11.2. Challenges
11.2.1 Lack of integration standards for laboratory informatics
11.2.2 Stringent Regulations
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Single-Use Bioreactors Market: SWOT Analysis
